Jerusalem, Israel

Tamar Peretz-Yablonsky

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hadasit Medical Research Services and Development Ltd.. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamar Peretz-Yablonsky. Retrieved from https://idiyas.com/inventor/tamar-peretz-yablonsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tamar Peretz-Yablonsky: Innovator in Cancer Therapy

Introduction

Tamar Peretz-Yablonsky is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of immunotherapy, particularly in cancer treatment. With a total of 2 patents, her work focuses on innovative methods that enhance T cell modulation for improved patient outcomes.

Latest Patents

Tamar's latest patents include groundbreaking inventions aimed at cancer therapy. The first patent, titled "Methods for cancer therapy using isolated NTB-A ectodomain polypeptides," is directed towards immunotherapy. This invention provides compositions and methods for improved T cell modulation both ex vivo and in vivo, specifically targeting cancer and other pathologies. The use of soluble NTB-A polypeptides or agonists is emphasized for treating cancer patients and preventing cytopenia in susceptible individuals.

The second patent, "Cell compositions and methods for cancer therapy," also focuses on immunotherapy. Similar to her first patent, it provides compositions and methods for enhanced T cell modulation for cancer treatment. The embodiments of this invention further explore the use of soluble NTB-A polypeptides or agonists for the treatment of cancer patients and the ex vivo preparation of improved cell compositions.

Career Highlights

Tamar is associated with Hadasit Medical Research Services and Development Ltd., where she continues to advance her research in cancer therapy. Her work is characterized by a commitment to developing innovative solutions that can significantly impact patient care.

Collaborations

Tamar collaborates with notable colleagues, including Abraham Rutenberg and Ronny Uzana. These partnerships enhance her research efforts and contribute to the development of effective cancer therapies.

Conclusion

Tamar Peretz-Yablonsky is a dedicated inventor whose work in immunotherapy is paving the way for new cancer treatment methods. Her innovative patents reflect her commitment to improving patient outcomes and advancing medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…